Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

FANALE, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.680
EU - Europa 5.537
AS - Asia 4.523
SA - Sud America 726
AF - Africa 116
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 21.603
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.467
SG - Singapore 1.764
RU - Federazione Russa 1.514
CN - Cina 1.136
IT - Italia 1.053
FI - Finlandia 783
DE - Germania 658
BR - Brasile 595
HK - Hong Kong 457
VN - Vietnam 404
GB - Regno Unito 275
PL - Polonia 252
UA - Ucraina 222
FR - Francia 216
IE - Irlanda 149
JP - Giappone 149
CA - Canada 127
SE - Svezia 126
IN - India 118
KR - Corea 94
BD - Bangladesh 71
TR - Turchia 58
RO - Romania 55
IQ - Iraq 53
NL - Olanda 52
BE - Belgio 48
AR - Argentina 40
MX - Messico 38
AT - Austria 37
ES - Italia 33
ZA - Sudafrica 26
CI - Costa d'Avorio 22
IR - Iran 22
UZ - Uzbekistan 20
ID - Indonesia 19
PK - Pakistan 19
EC - Ecuador 17
CO - Colombia 16
VE - Venezuela 16
MA - Marocco 15
MY - Malesia 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
NP - Nepal 13
PH - Filippine 13
CL - Cile 12
KE - Kenya 12
AU - Australia 11
KZ - Kazakistan 11
CZ - Repubblica Ceca 10
JM - Giamaica 10
AZ - Azerbaigian 9
EG - Egitto 9
IL - Israele 9
PE - Perù 9
TN - Tunisia 8
DZ - Algeria 7
EU - Europa 7
LT - Lituania 7
PY - Paraguay 7
SA - Arabia Saudita 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
BG - Bulgaria 6
CR - Costa Rica 6
KG - Kirghizistan 6
BO - Bolivia 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
JO - Giordania 4
LV - Lettonia 4
PA - Panama 4
PS - Palestinian Territory 4
TW - Taiwan 4
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
NI - Nicaragua 3
OM - Oman 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
GD - Grenada 2
HU - Ungheria 2
LB - Libano 2
MD - Moldavia 2
MM - Myanmar 2
NG - Nigeria 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
Totale 21.580
Salva come PNG Salva come JPEG
Città #
Ashburn 1.454
Fairfield 1.130
Singapore 1.105
Chandler 626
Woodbridge 604
San Jose 571
Houston 478
Wilmington 471
Ann Arbor 461
Seattle 439
Hong Kong 429
Cambridge 369
Palermo 299
Moscow 272
Zgierz 205
Los Angeles 185
Santa Clara 183
Council Bluffs 177
New York 176
Beijing 171
Helsinki 159
The Dalles 153
Dublin 147
Dallas 145
Medford 145
Tokyo 144
Ho Chi Minh City 135
Nanjing 118
Jacksonville 107
Des Moines 106
Frankfurt am Main 104
Lauterbourg 98
Rome 98
Altamura 96
Hanoi 95
Boardman 93
Princeton 93
Hefei 78
Lawrence 78
Dearborn 70
San Diego 68
Chicago 67
São Paulo 61
Phoenix 51
Buffalo 50
Ludwigshafen am Rhein 50
Brussels 47
Orem 46
London 45
Jinan 44
Warsaw 42
Milan 39
Tulsa 39
Seoul 37
Nuremberg 35
Shenyang 35
Hebei 34
Atlanta 33
Denver 33
Bremen 31
Kumar 30
Montreal 30
Munich 29
Tianjin 29
Brooklyn 28
Nanchang 27
Kitzingen 26
Abidjan 22
Poplar 22
Venice 22
Amsterdam 21
Changsha 21
Johannesburg 21
Rio de Janeiro 21
Stockholm 21
Guangzhou 20
Toronto 20
Chennai 19
Izmir 19
Baghdad 18
Ningbo 18
Falls Church 17
Haiphong 17
Tashkent 17
Boston 16
Columbus 16
Jiaxing 16
San Paolo di Civitate 16
Turku 16
Ankara 15
Brasília 15
Mumbai 15
Seongnam 15
Hangzhou 14
Pune 14
Saint Petersburg 14
Verona 14
Manchester 13
Paris 13
Vienna 13
Totale 13.724
Salva come PNG Salva come JPEG
Nome #
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 354
Dietary restriction: could it be considered as speed bump on tumor progression road? 326
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 326
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 325
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 320
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 315
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 311
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 311
Anti-endothelin drugs in solid tumors 299
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 293
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 293
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 292
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 290
Breast cancer genome-wide association studies: there is strength in numbers 288
A headlight on liquid biopsies: a challenging tool for breast cancer management 288
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 282
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 273
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 272
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 272
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 272
Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer 268
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 267
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 267
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 267
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 266
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 261
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 259
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 256
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 254
The role of Aurora-A inhibitors in cancer therapy. 250
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 250
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 249
VUS variants in BRCA genes of hereditary breast/ovarian cancer 242
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 241
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 240
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 238
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 237
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 237
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 237
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 236
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 234
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 230
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 229
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 224
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming 222
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway 221
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer 219
Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma 219
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 218
Gene signatures in CRC and liver metastasis 215
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 215
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER 214
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer 214
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 208
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 207
BRCA1/2 variants of uncertain clinical significance in patients with famlial and hereditary breast/ovarian cancer 201
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression 200
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 199
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? 198
Non-coding RNAs functioning in colorectal cancer stem cells 198
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning 194
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 192
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? 187
Effects of Dietary Restriction on Cancer Development and Progression 184
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. 179
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells 179
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? 178
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) 177
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin 176
The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis 174
MUTYH-associated tumor syndrome: The other face of MAP 173
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 172
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes 169
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 168
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 166
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 164
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay 162
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 159
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? 158
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer 157
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 156
Primary epithelial ovarian neoplasms: New conceptsconcerning origin, pathogenesis and classification based on morphology, immunomarkers, molecular features, and gene expression studies 156
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 155
Circular RNA in Exosomes 149
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? 149
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? 149
Liquid Biopsy in Gastrointestinal Stromal Tumor 147
BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 146
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome 145
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 144
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength 142
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? 136
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? 134
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? 131
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon 128
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints 125
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 123
Scientific Communication and oncology – "The bridge between knowledge and patients" 123
role of CML exosomes in the crosstalk between chronic myelogenous leukaemia and bone marrow-derived cells 118
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer 117
Totale 21.550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.181
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.335 68 289 47 57 75 60 67 69 126 144 130 203
2022/20231.733 196 343 34 229 192 242 83 128 185 11 58 32
2023/2024972 42 101 53 60 58 212 104 135 6 46 11 144
2024/20252.716 23 225 216 170 140 110 308 245 123 357 338 461
2025/20268.394 724 290 468 711 897 1.319 1.133 816 594 865 282 295
2026/2027191 191 0 0 0 0 0 0 0 0 0 0 0
Totale 22.168